2023年美国癌症数据解读及对中国癌症防治的启示

周昌明; 王泽洲; 郑莹

doi:10.19401/j.cnki.1007-3639.2023.02.004

您当前的位置：

首页 >

文章列表页 >

2023年美国癌症数据解读及对中国癌症防治的启示

专家述评 | 更新时间：2025-12-31

- 2023年美国癌症数据解读及对中国癌症防治的启示
- Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China
- 中国癌症杂志 2023年33卷第2期页码：117-125
- 作者机构：
  
  1. 复旦大学附属肿瘤医院肿瘤预防部，复旦大学上海医学院肿瘤学系，上海 200032
  2. 上海肿瘤疾病人工智能工程技术研究中心，上海 200032
- 作者简介：
  
  [ "周昌明（ORCID: 0000-0001-7863-428X），博士。" ]
  [ "郑莹，复旦大学附属肿瘤医院肿瘤预防部主任，主任医师，教授，硕士研究生导师，毕业于上海医科大学，医学硕士。长期从事肿瘤预防控制工作，涵盖肿瘤登记和监测、常见肿瘤社区防治干预、肿瘤筛查和早发现及肿瘤防治的健康教育和科普。开展肿瘤病因和预后研究，建立起了以人群为基础的乳腺癌患者队列和大肠癌筛查人群队列。指导健康人和癌症患者建立健康的生活方式，执笔的《中国乳腺癌患者生活方式指南》是我国第一个癌症患者预防指南。曾经担任上海市重点公共卫生项目《社区居民大肠癌筛查项目》的技术负责人，组织编写和发布上海市抗癌协会《居民常见恶性肿瘤筛查和预防推荐》，为医疗机构和个人的癌症早发现和筛查提供指导。共发表学术论文100余篇，其中第一作者或通讯作者的文章90余篇，主编和参编20余部专著，获中华预防医学科技奖2项，上海市科技进步奖1项，上海医学科技奖1项，上海抗癌科技奖1项。主要学术兼职：上海市抗癌协会常务理事，上海市抗癌协会癌症预防与筛查专业委员会主任委员，中国抗癌协会乳腺癌专业委员会康复学组组长，中国临床肿瘤学会（CSCO）肿瘤大数据专家委员会常务委员，中国抗癌协会多原发和不明原因肿瘤专业委员会常务委员，中国抗癌协会乳腺癌专委会、科普专委会、肿瘤流行病学专委会、筛查和早诊早治专委会委员，中国控制吸烟协会控烟与肺癌防治专业委员会常务委员。" ]
- 基金信息：
  
  上海市老龄化和妇儿健康研究专项(2020YJZX0206);中国癌症基金会科研项目(NH2018001)
- DOI：10.19401/j.cnki.1007-3639.2023.02.004
  中图分类号： R737.9
- 收稿：2023-02-02，
  
  修回：2023-02-14，
  
  纸质出版：2023-02-28
- 稿件说明：
移动端阅览
周昌明, 王泽洲, 郑莹. 2023年美国癌症数据解读及对中国癌症防治的启示[J]. 中国癌症杂志, 2023,33(2):117-125.

Changming ZHOU, Zezhou WANG, Ying ZHENG. Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China[J]. China Oncology, 2023, 33(2): 117-125.
周昌明, 王泽洲, 郑莹. 2023年美国癌症数据解读及对中国癌症防治的启示[J]. 中国癌症杂志, 2023,33(2):117-125. DOI： 10.19401/j.cnki.1007-3639.2023.02.004.

Changming ZHOU, Zezhou WANG, Ying ZHENG. Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China[J]. China Oncology, 2023, 33(2): 117-125. DOI： 10.19401/j.cnki.1007-3639.2023.02.004.

摘要

美国癌症协会发表的美国癌症统计数据预计2023年美国全年新发恶性肿瘤病例1 958 310例，死亡609 820例。美国的癌症死亡率在1991年达到峰值后持续加速下降，治疗的进步使得患者生存得到改善，减少吸烟人数、普及癌症筛查是其主要原因；2020年COVID-19大流行造成350 831人死亡，位列2020年死因第3位，同时造成包括癌症在内的其他多种死因显著增加，但疫情对癌症死亡的影响尚未被纳入评估。通过对2020年GLOBOCAN数据库中中国和美国数据进行对比分析发现，尽管中美癌症发病和死亡存在较大差异，但是美国癌症防治的经验值得中国借鉴，我们应努力提高肿瘤诊治规范化程度、提升医疗服务资源可及性以提升患者生存率，优化筛查模式、提升筛查效率，癌症筛查覆盖率，同时进一步提高HPV疫苗接种率将有效地降低癌症死亡。

Abstract

In the year 2023

1 958 310 new cancer cases and 609 820 cancer deaths are projected to occur in the United States

estimated by Cancer Statistics

published by American Cancer Society. An accelerated decline in mortality rate of cancer continues since it reached the peak in 1991. The treatment advance brought survival benefit to patients which mainly contribute to the decline along with tobacco control and screening. COVID-19 pandemic caused 350 831 mortality and ranked 3rd in cause of death in 2020

and the mortality had a significant increase in multiple causes of death including cancer. By comparing the data of China and the United States released by GLOBOCAN database in 2020

it is found that

although the influence of the pandemic on cancer has not been evaluated. Although the incidence and mortality of cancer differ between US and China

the experiences are worth learning. Improving the standardization of diagnosis and treatment

enhancing the accessibility of cancer health care

upgrading the coverage of screening and increasing the human papillomavirus (HPV) vaccination rate are proven to be effective ways to reduce the mortality of cancer.

关键词

Keywords

references

SIEGEL R L , MILLER K D , WAGLE N S , et al. Cancer statistics, 2023 [J ] . CA Cancer J Clin , 2023 , 73 ( 1 ): 17 - 48 . DOI: 10.3322/caac.v73.1 http://doi.org/10.3322/caac.v73.1 https://onlinelibrary.wiley.com/toc/15424863/73/1 https://onlinelibrary.wiley.com/toc/15424863/73/1

ISLAMI F , GODING SAUER A , MILLER K D , et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States [J ] . CA Cancer J Clin , 2018 , 68 ( 1 ): 31 - 54 . DOI: 10.3322/caac.21440 http://doi.org/10.3322/caac.21440 http://doi.wiley.com/10.3322/caac.21440 http://doi.wiley.com/10.3322/caac.21440

MENVIELLE G , KULHÁNOVÁ I , BRYÈRE J , et al. Tobacco-attributable burden of cancer according to socioeconomic position in France [J ] . Int J Cancer , 2018 , 143 ( 3 ): 478 - 485 . DOI: 10.1002/ijc.31328 http://doi.org/10.1002/ijc.31328

CORNELIUS M E , LORETAN C G , WANG T W , et al. Tobacco product use among adults-United States, 2020 [J ] . MMWR Morb Mortal Wkly Rep , 2022 , 71 ( 11 ): 397 - 405 . DOI: 10.15585/mmwr.mm7111a1 http://doi.org/10.15585/mmwr.mm7111a1 http://www.cdc.gov/mmwr/volumes/71/wr/mm7111a1.htm?s_cid=mm7111a1_w http://www.cdc.gov/mmwr/volumes/71/wr/mm7111a1.htm?s_cid=mm7111a1_w

U.S. Department of Health and Human Services . The health consequences of smoking--50 years of progress: a report of the surgeon general [R ] . Atlanta : U.S. : Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 .

SASAKI K , STROM S S , O'BRIEN S , et al. Relative survival in patients with chronic-phase chronic myeloid leukemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials [J ] . Lancet Haematol , 2015 , 2 ( 5 ): e186 -e193. DOI: 10.1016/S2352-3026(15)00048-4 http://doi.org/10.1016/S2352-3026(15)00048-4 https://linkinghub.elsevier.com/retrieve/pii/S2352302615000484 https://linkinghub.elsevier.com/retrieve/pii/S2352302615000484

Surveillance, Epidemiology, and End Results (SEER) Program . SEER*Stat database: incidence-SEER research data, 17 registries (2000-2019), based on the November 2021 submission [D ] . National Cancer Institute , Division of Cancer Control and Population Sciences, Surveillance Research Program , 2022 .

YABROFF K R , WU X C , NEGOITA S , et al. Association of the COVID-19 pandemic with patterns of statewide cancer services [J ] . J Natl Cancer Inst , 2022 , 114 ( 6 ): 907 - 909 . DOI: 10.1093/jnci/djab122 http://doi.org/10.1093/jnci/djab122 https://academic.oup.com/jnci/article/114/6/907/6307727 https://academic.oup.com/jnci/article/114/6/907/6307727

孙可欣 , 郑荣寿 , 张思维 , 等 . 2015年中国分地区恶性肿瘤发病和死亡分析 [J ] . 中国肿瘤 , 2019 , 28 ( 1 ): 1 - 11 .

SUN K X , ZHENG R S , ZHANG S W , et al. Report of cancer incidence and mortality in different areas of China, 2015 [J ] . China Cancer , 2019 , 28 ( 1 ): 1 - 11 .

YANG L L , ZHANG X C , YANG X N , et al. Lung cancer treatment disparities in China: a question in need of an answer [J ] . Oncologist , 2014 , 19 ( 10 ): 1084 - 1090 . DOI: 10.1634/theoncologist.2014-0007 http://doi.org/10.1634/theoncologist.2014-0007

健康中国行动推进委员会 . 健康中国行动(2019—2030年) [EB/OL ] . [ 2023-01-29 ] . http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.

FERLAY J E M L F . Global cancer observatory: cancer today [EB/OL ] . [2023/2/16 ] . https://gco.iarc.fr/today https://gco.iarc.fr/today https://gco.iarc.fr/today.

ZENG H M , CHEN W Q , ZHENG R S , et al. Changing cancer survival in China during 2003-2015: a pooled analysis of 17 population-based cancer registries [J ] . Lancet Glob Health , 2018 , 6 ( 5 ): e555 -e567. DOI: 10.1016/S2214-109X(18)30127-X http://doi.org/10.1016/S2214-109X(18)30127-X https://linkinghub.elsevier.com/retrieve/pii/S2214109X1830127X https://linkinghub.elsevier.com/retrieve/pii/S2214109X1830127X

ALLEMANI C , MATSUDA T , DI CARLO V , et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J ] . Lancet , 2018 , 391 ( 10125 ): 1023 - 1075 . DOI: 10.1016/S0140-6736(17)33326-3 http://doi.org/10.1016/S0140-6736(17)33326-3 https://linkinghub.elsevier.com/retrieve/pii/S0140673617333263 https://linkinghub.elsevier.com/retrieve/pii/S0140673617333263

中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组 . 前列腺癌筛查中国专家共识(2021年版) [J ] . 中国癌症杂志 , 2021 , 31 ( 5 ): 435 - 440 .

Prostate Cancer Group, Urogenital and Reproductive System Tumor Professional Committee, China Anti-Cancer Association . China expert consensus on prostate cancer screening (2021 edition) [J ] . China Oncol , 2021 , 31 ( 5 ): 435 - 440 .

石菊芳 , 曹梦迪 , 严鑫鑫 , 等 . 肝癌筛查在中国人群中的可及性: 一项探索性分析 [J ] . 中华流行病学杂志 , 2022 , 43 ( 6 ): 906 - 914 .

SHI J F , CAO M D , YAN X X , et al. Access to liver cancer screening and surveillance in populations in China: an exploratory analysis [J ] . Chin J Epidemiol , 2022 , 43 ( 6 ): 906 - 914 .

MILLER K D , NOGUEIRA L , DEVASIA T , et al. Cancer treatment and survivorship statistics, 2022 [J ] . CA Cancer J Clin , 2022 , 72 ( 5 ): 409 - 436 . DOI: 10.3322/caac.v72.5 http://doi.org/10.3322/caac.v72.5 https://onlinelibrary.wiley.com/toc/15424863/72/5 https://onlinelibrary.wiley.com/toc/15424863/72/5

SUNG H , FERLAY J , SIEGEL R L , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.v71.3 http://doi.org/10.3322/caac.v71.3 https://onlinelibrary.wiley.com/toc/15424863/71/3 https://onlinelibrary.wiley.com/toc/15424863/71/3

CHEN W Q , ZHANG S W , ZOU X N , et al. Cancer incidence and mortality in China, 2006 [J ] . Chin J Cancer Res , 2011 , 23 ( 1 ): 3 - 9 . DOI: 10.1007/s11670-011-0003-9 http://doi.org/10.1007/s11670-011-0003-9 http://link.springer.com/10.1007/s11670-011-0003-9 http://link.springer.com/10.1007/s11670-011-0003-9

SIEGEL R L , MILLER K D , GODING SAUER A , et al. Colorectal cancer statistics, 2020 [J ] . CA Cancer J Clin , 2020 , 70 ( 3 ): 145 - 164 . DOI: 10.3322/caac.v70.3 http://doi.org/10.3322/caac.v70.3 https://onlinelibrary.wiley.com/toc/15424863/70/3 https://onlinelibrary.wiley.com/toc/15424863/70/3

DAVIDSON K W , BARRY M J , MANGIONE C M , et al. Screening for colorectal cancer [J ] . JAMA , 2021 , 325 ( 19 ): 1965 . DOI: 10.1001/jama.2021.6238 http://doi.org/10.1001/jama.2021.6238 https://jamanetwork.com/journals/jama/fullarticle/2779985 https://jamanetwork.com/journals/jama/fullarticle/2779985

CHEN H D , LI N , REN J S , et al. Participation and yield of a population-based colorectal cancer screening programme in China [J ] . Gut , 2019 , 68 ( 8 ): 1450 - 1457 . DOI: 10.1136/gutjnl-2018-317124 http://doi.org/10.1136/gutjnl-2018-317124

CHEN H D , LU B , DAI M . Colorectal cancer screening in China: status, challenges, and prospects-China, 2022 [J ] . China CDC Wkly , 2022 , 4 ( 15 ): 322 - 328 .

ROSENBLUM H G , LEWIS R M , GARGANO J W , et al. Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018 [J ] . Ann Intern Med , 2022 , 175 ( 7 ): 918 - 926 . DOI: 10.7326/M21-3798 http://doi.org/10.7326/M21-3798 https://www.acpjournals.org/doi/10.7326/M21-3798 https://www.acpjournals.org/doi/10.7326/M21-3798

PINGALI C , YANKEY D , ELAM-EVANS L D , et al. National vaccination coverage among adolescents aged 13-17 years-national immunization survey-teen, United States, 2021 [J ] . MMWR Morb Mortal Wkly Rep , 2022 , 71 ( 35 ): 1101 - 1108 . DOI: 10.15585/mmwr.mm7135a1 http://doi.org/10.15585/mmwr.mm7135a1 http://www.cdc.gov/mmwr/volumes/71/wr/mm7135a1.htm?s_cid=mm7135a1_w http://www.cdc.gov/mmwr/volumes/71/wr/mm7135a1.htm?s_cid=mm7135a1_w

宋祎凡 , 刘晓雪 , 尹遵栋 , 等 . 2018—2020年中国9-45岁女性人乳头瘤病毒疫苗估算接种率 [J ] . 中国疫苗和免疫 , 2021 , 27 ( 5 ): 570 - 575 .

SONG Y F , LIU X X , YIN Z D , et al. Human papillomavirus vaccine coverage among the 9-45-year-old female population of China in 2018-2020 [J ] . Chin J Vaccines Immun , 2021 , 27 ( 5 ): 570 - 575 .

World Health Organization . Global strategy to accelerate the elimination of cervical cancer as a public health problem [CP/OL ] .

中华人民共和国卫生健康委员会 . 加速消除宫颈癌行动计划(2023—2030年) [EB/OL ] . [ 2023-01-30 ] . http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=42c2c95b6db84f9cb356cfdf1edbbac7 http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=42c2c95b6db84f9cb356cfdf1edbbac7 http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=42c2c95b6db84f9cb356cfdf1edbbac7.

BONANNI P , ZANELLA B , SANTOMAURO F , et al. Safety and perception: what are the greatest enemies of HPV vaccination programmes? [J ] . Vaccine , 2018 , 36 ( 36 ): 5424 - 5429 . DOI: S0264-410X(17)30730-2 http://doi.org/S0264-410X(17)30730-2

郑莹 , 周昌明 . 综合防治, 抗击癌症的必由之路: 美国癌症数据的启示 [J ] . 中华结直肠疾病电子杂志 , 2018 , 7 ( 2 ): 102 - 108 .

ZHENG Y , ZHOU C M . Comprehensive strategies, the route leading to cancer prevention and control: what we learned from US cancer statistics [J ] . Chin J Colorectal Dis Electron Ed , 2018 , 7 ( 2 ): 102 - 108 .

浏览量

12157

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

2025年美国癌症统计数据解读及对中国癌症防治工作的借鉴意义

中国年轻女性乳腺癌发病、死亡近30年的变迁情况及趋势研究

上海市结直肠癌筛查项目参与状态对结直肠癌发病、分期及患者生存结局的影响

人工智能赋能癌症协同药物组合预测的现状与挑战

上海市癌症患者化疗所致恶心呕吐的横断面研究